Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. 

Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime.

 DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve.
| $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology


Health Care

Medical Devices

Anteris Technologies

Wayne Paterson

Julian Chick

Denice Lachapelle

Dounia M.

Christopher Meduri

Wenyi Gu

Stephen Denaro

Matthew Mcdonnell

David St. Denis

The Regulatory and Quality Affairs team at Anteris Technologies ensures that the DurAVR™ Transcatheter Heart Valve (THV) System complies with all medical regulations and quality standards. This team manages the approval processes with health authorities, oversees clinical trial regulations, maintains product quality, and ensures rigorous standards are met to deliver safe and effective heart valve solutions for patients.

Regulatory and Quality Affairs

Engineering Team

Leadership Team

Operations and Project Management

Regulatory and Quality Affairs

About

Team members

Other teams at Anteris Technologies

Engineering Team

Leadership Team

Operations and Project Management